Non-Invasive Monitoring Device Market: Information by Type (Cardiac Monitoring Devices, Brain Monitoring Devices, Blood Pressure Monitoring Devices, Anesthesia Monitoring Devices and Blood Glucose Monitoring Devices), Modality (Table-Top Devices and Wearable Devices), Application (Cardiology, Neurology and Oncology), End User (Hospitals & Clinics, Diagnostic Centers, Research & Academic Institutes) and Region (Americas, Europe, Asia-Pacific and Middle East & Africa) - Forecast till 2027
GET FREE SAMPLE COPY @ https://www.marketresearchfuture.com/sample_request/1506
Non-Invasive Monitoring Devices Market to Surpass a Valuation of USD 21,500 Million by 2023
Major Companies in Non-Invasive Monitoring Device Market Analyzed are:
General Electric Company (US), Medtronic PLC (Ireland), KONINKLIJKE PHILIPS NV (Netherlands), Abbott (US), Omron Corporation (Japan), Vaso Corporation (US), Integrity Applications (Israel), CAS Medical Systems, Inc. (US), A&D Medical Inc. (Japan), Tensys Medical Inc (US), OrSense Ltd (Israel), CNSystems Medizintechnik AG (Austria), NIMedical (Israel) and Advanced Brain Monitoring, Inc (US).
Non-Invasive Monitoring Device Market Highlights
Non-invasive monitoring devices enable measurement of vital signs of the patient without the need of insertion in the body. Non-invasive monitoring devices are witnessing a rage and top the list of clinicianswish list.The global non-invasive monitoring device market is experiencing a demand cliff and the market is expected to undergo frenzy.
According to Market Research Future (MRFR), the global non-invasive monitoring device market is expected to garner a valuation of USD 21,586.2 MN by the end of 2023. In its recently published analysis, MRFR also asserts that the market would register a CAGR of over 6.8% over the assessment period (2016-2023).
Global Non-Invasive Monitoring Device Market – Segments
The report is segmented into four dynamics to widen the scope of understanding,
By Type: Cardiac Monitoring Devices (Electrocardiography and Cardiac Output Monitors), Brain Monitoring Devices, Blood Pressure Monitoring Devices, Anesthesia Monitoring Devices, And Blood Glucose Monitoring Devices, among others.
By Modality: Table-Top Devices and Wearable Devices, among others.
By End Users: Hospital & Clinics, Diagnostic Centers, and Research & Academic Institutes, among others.
By Regions: North America, Europe, Asia Pacific, and the Rest-of-the-World.
Browse More Information On This Report at @ https://www.marketresearchfuture.com/reports/non-invasive-monitoring-device-market-1506
Industry/ Innovation/ Related News:
12 Jun 2019 —- Nemaura Medical received European approval for the first non-invasive continuous glucose monitor branded SugarBEAT. SugarBEAT owing to its convenience satisfies the unmet need of painless non-invasive glucose testing. Sugar BEAT can be connected to Bluetooth-enabled smartphone. SugarBEAT is a disposable adhesive patch possessing a rechargeable sensor which continuouslymeasures glucose readingsevery 5 minutes. SugarBEAT enables real-time glucose profile and analysis of data to detect patterns. Nemaura Medical is expected to launch SugarBEAT in Europe in last quarter of 2019.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
